Global 3D Biological Printing Market

3D Biological Printing Comprehensive Study by Application (Medical (Tissue and Organ Generation, Medical Pills, Prosthetic and Implants, Dental), Biosensors, Consumer/Personal Product Testing, Bioinks, Food and Animal Product), Technology (Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based, Others), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Component (3D Bioprinters, Biomaterials, Scaffolds) Players and Region - Global Market Outlook to 2028

3D Biological Printing Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About 3D Biological Printing
3D biological printing is a medical application of 3D printers. It contains 3D printing of biological tissues as well as organs through layering of living cells. The process of 3D biological printing mainly comprises of three stages, namely, pre-biological printing, biological printing, and post-biological printing. During the process of 3D biological printing, the cell function and viability of the output construct is preserved, which can be used for R&D in various medical areas. 3D biological printing is mainly employed for developing organ and tissue constructs, which can be used for R&D of drugs, scaffolds, and development of medical implants.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia Pacific
UnitValue (USD Million)


The global 3D Biological printing market is highly competitive in nature, with key players concentrated on producing awareness regarding the 3D biological printing industry. Key players in the 3D biological printing market host exhibition as well as seminars to display and encourage the use of 3D biological printers for varied medical applications. The prominent players in the market have adopted numerous strategies for development, such as product innovation, product launches & approvals, and investment in R&D for advancements in 3D biological printers, to endure the competitive environment of the global 3D biological printing market. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global 3D Biological Printing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Organovo Holdings Inc. (United States), EnvisionTEC (United States), Nano3D Biosciences, Inc. (United States), Cyfuse Biomedical K.K. (Japan), BioBots (United States), Aspect Biosystems Ltd. (United States), 3Dynamic Systems Ltd (United Kingdom), Stratavs (Israel), Medpain (United States) and Formlabs (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global 3D Biological Printing market by , Application (Medical [Tissue and Organ Generation, Medical Pills, Prosthetic and Implants, Dental], Biosensors, Consumer/Personal Product Testing, Bioinks and Food and Animal Product) and Region.

On the basis of application, Medical segment is dominating the market in the year 2022

On the basis of geography, the market of 3D Biological Printing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2022. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Technology, the sub-segment i.e. Magnetic Levitation will boost the 3D Biological Printing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Material, the sub-segment i.e. Cells will boost the 3D Biological Printing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Component, the sub-segment i.e. 3D Bioprinters will boost the 3D Biological Printing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increase in Usage of 3d Printing in Cosmetic Surgeries and Growing Inventions in the 3d Bio Printing Are Expected To Further Supplement the 3d Bio Printing

Market Growth Drivers:
Growing Geriatric Population and Increasing Organ Transplant Requirements

Challenges:
Dearth of skilled professionals

Restraints:
Rising Concern Regarding Operational Challenges

Opportunities:
Increase in Stem Cell Research and Growth in Awareness Related To 3d Bioprinting and Advancements in Technology & It within the Healthcare Industry

Market Leaders and their expansionary development strategies
In October 2021, 3D Systems announced the acquired Volumetric Biotechnologies, a Houston-based biotech company co-founded by Drs. Jordan Miller and Bagrat Grigoryan. Volumetric’s mission has from the outset been to develop the ability to manufacture human organs using bioprinting methods. This acquisition, 3D Systems plans to establish a world-class research capability in Houston, Texas, a region committed to leadership in technologies related to life sciences.
On 3rd April 2019, ADAM launched 3D biological printing of organic bone structures. It uses innovative approaches and combination of new materials for 3D printing. One is biopolymer and another one is a ceramic bioglass. The market players have adopted new product launches, product development, product approval, partnerships, agreement, and collaborations as its key business development strategies to guarantee their global dominance in 3D biological printing market.


Key Target Audience
Private Research Organization, Heath care Organizations, Government Research Organizations, Government Agencies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Medical [Tissue and Organ Generation, Medical Pills, Prosthetic and Implants
  • Dental]
  • Biosensors
  • Consumer/Personal Product Testing
  • Bioinks
  • Food and Animal Product
By Technology
  • Magnetic Levitation
  • Inkjet-based
  • Syringe-based
  • Laser-based
  • Others

By Material
  • Cells
  • Hydrogels
  • Extracellular Matrices
  • Biomaterials

By Component
  • 3D Bioprinters
  • Biomaterials
  • Scaffolds

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Geriatric Population
      • 3.2.2. Increasing Organ Transplant Requirements
    • 3.3. Market Challenges
      • 3.3.1. Dearth of skilled professionals
    • 3.4. Market Trends
      • 3.4.1. Increase in Usage of 3d Printing in Cosmetic Surgeries
      • 3.4.2. Growing Inventions in the 3d Bio Printing Are Expected To Further Supplement the 3d Bio Printing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global 3D Biological Printing, by Application, Technology, Material, Component and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global 3D Biological Printing (Value)
      • 5.2.1. Global 3D Biological Printing by: Application (Value)
        • 5.2.1.1. Medical [Tissue and Organ Generation, Medical Pills, Prosthetic and Implants
        • 5.2.1.2. Dental]
        • 5.2.1.3. Biosensors
        • 5.2.1.4. Consumer/Personal Product Testing
        • 5.2.1.5. Bioinks
        • 5.2.1.6. Food and Animal Product
      • 5.2.2. Global 3D Biological Printing by: Technology (Value)
        • 5.2.2.1. Magnetic Levitation
        • 5.2.2.2. Inkjet-based
        • 5.2.2.3. Syringe-based
        • 5.2.2.4. Laser-based
        • 5.2.2.5. Others
      • 5.2.3. Global 3D Biological Printing by: Material (Value)
        • 5.2.3.1. Cells
        • 5.2.3.2. Hydrogels
        • 5.2.3.3. Extracellular Matrices
        • 5.2.3.4. Biomaterials
      • 5.2.4. Global 3D Biological Printing by: Component (Value)
        • 5.2.4.1. 3D Bioprinters
        • 5.2.4.2. Biomaterials
        • 5.2.4.3. Scaffolds
      • 5.2.5. Global 3D Biological Printing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global 3D Biological Printing (Price)
  • 6. 3D Biological Printing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Organovo Holdings Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. EnvisionTEC (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Nano3D Biosciences, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cyfuse Biomedical K.K. (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioBots (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Aspect Biosystems Ltd. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. 3Dynamic Systems Ltd (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Stratavs (Israel)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medpain (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Formlabs (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global 3D Biological Printing Sale, by Application, Technology, Material, Component and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global 3D Biological Printing (Value)
      • 7.2.1. Global 3D Biological Printing by: Application (Value)
        • 7.2.1.1. Medical [Tissue and Organ Generation, Medical Pills, Prosthetic and Implants
        • 7.2.1.2. Dental]
        • 7.2.1.3. Biosensors
        • 7.2.1.4. Consumer/Personal Product Testing
        • 7.2.1.5. Bioinks
        • 7.2.1.6. Food and Animal Product
      • 7.2.2. Global 3D Biological Printing by: Technology (Value)
        • 7.2.2.1. Magnetic Levitation
        • 7.2.2.2. Inkjet-based
        • 7.2.2.3. Syringe-based
        • 7.2.2.4. Laser-based
        • 7.2.2.5. Others
      • 7.2.3. Global 3D Biological Printing by: Material (Value)
        • 7.2.3.1. Cells
        • 7.2.3.2. Hydrogels
        • 7.2.3.3. Extracellular Matrices
        • 7.2.3.4. Biomaterials
      • 7.2.4. Global 3D Biological Printing by: Component (Value)
        • 7.2.4.1. 3D Bioprinters
        • 7.2.4.2. Biomaterials
        • 7.2.4.3. Scaffolds
      • 7.2.5. Global 3D Biological Printing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global 3D Biological Printing (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. 3D Biological Printing: by Application(USD Million)
  • Table 2. 3D Biological Printing Medical [Tissue and Organ Generation, Medical Pills, Prosthetic and Implants , by Region USD Million (2017-2022)
  • Table 3. 3D Biological Printing Dental] , by Region USD Million (2017-2022)
  • Table 4. 3D Biological Printing Biosensors , by Region USD Million (2017-2022)
  • Table 5. 3D Biological Printing Consumer/Personal Product Testing , by Region USD Million (2017-2022)
  • Table 6. 3D Biological Printing Bioinks , by Region USD Million (2017-2022)
  • Table 7. 3D Biological Printing Food and Animal Product , by Region USD Million (2017-2022)
  • Table 8. 3D Biological Printing: by Technology(USD Million)
  • Table 9. 3D Biological Printing Magnetic Levitation , by Region USD Million (2017-2022)
  • Table 10. 3D Biological Printing Inkjet-based , by Region USD Million (2017-2022)
  • Table 11. 3D Biological Printing Syringe-based , by Region USD Million (2017-2022)
  • Table 12. 3D Biological Printing Laser-based , by Region USD Million (2017-2022)
  • Table 13. 3D Biological Printing Others , by Region USD Million (2017-2022)
  • Table 14. 3D Biological Printing: by Material(USD Million)
  • Table 15. 3D Biological Printing Cells , by Region USD Million (2017-2022)
  • Table 16. 3D Biological Printing Hydrogels , by Region USD Million (2017-2022)
  • Table 17. 3D Biological Printing Extracellular Matrices , by Region USD Million (2017-2022)
  • Table 18. 3D Biological Printing Biomaterials , by Region USD Million (2017-2022)
  • Table 19. 3D Biological Printing: by Component(USD Million)
  • Table 20. 3D Biological Printing 3D Bioprinters , by Region USD Million (2017-2022)
  • Table 21. 3D Biological Printing Biomaterials , by Region USD Million (2017-2022)
  • Table 22. 3D Biological Printing Scaffolds , by Region USD Million (2017-2022)
  • Table 23. South America 3D Biological Printing, by Country USD Million (2017-2022)
  • Table 24. South America 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 25. South America 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 26. South America 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 27. South America 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 28. Brazil 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 29. Brazil 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 30. Brazil 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 31. Brazil 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 32. Argentina 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 33. Argentina 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 34. Argentina 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 35. Argentina 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 36. Rest of South America 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 37. Rest of South America 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 38. Rest of South America 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 39. Rest of South America 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 40. Asia Pacific 3D Biological Printing, by Country USD Million (2017-2022)
  • Table 41. Asia Pacific 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 42. Asia Pacific 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 43. Asia Pacific 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 44. Asia Pacific 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 45. China 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 46. China 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 47. China 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 48. China 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 49. Japan 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 50. Japan 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 51. Japan 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 52. Japan 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 53. India 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 54. India 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 55. India 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 56. India 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 57. South Korea 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 58. South Korea 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 59. South Korea 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 60. South Korea 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 61. Taiwan 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 62. Taiwan 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 63. Taiwan 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 64. Taiwan 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 65. Australia 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 66. Australia 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 67. Australia 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 68. Australia 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 71. Rest of Asia-Pacific 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 72. Rest of Asia-Pacific 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 73. Europe 3D Biological Printing, by Country USD Million (2017-2022)
  • Table 74. Europe 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 75. Europe 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 76. Europe 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 77. Europe 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 78. Germany 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 79. Germany 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 80. Germany 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 81. Germany 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 82. France 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 83. France 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 84. France 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 85. France 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 86. Italy 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 87. Italy 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 88. Italy 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 89. Italy 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 90. United Kingdom 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 91. United Kingdom 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 92. United Kingdom 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 93. United Kingdom 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 94. Netherlands 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 95. Netherlands 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 96. Netherlands 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 97. Netherlands 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 98. Rest of Europe 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 99. Rest of Europe 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 100. Rest of Europe 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 101. Rest of Europe 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 102. MEA 3D Biological Printing, by Country USD Million (2017-2022)
  • Table 103. MEA 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 104. MEA 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 105. MEA 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 106. MEA 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 107. Middle East 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 108. Middle East 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 109. Middle East 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 110. Middle East 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 111. Africa 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 112. Africa 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 113. Africa 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 114. Africa 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 115. North America 3D Biological Printing, by Country USD Million (2017-2022)
  • Table 116. North America 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 117. North America 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 118. North America 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 119. North America 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 120. United States 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 121. United States 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 122. United States 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 123. United States 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 124. Canada 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 125. Canada 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 126. Canada 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 127. Canada 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 128. Mexico 3D Biological Printing, by Application USD Million (2017-2022)
  • Table 129. Mexico 3D Biological Printing, by Technology USD Million (2017-2022)
  • Table 130. Mexico 3D Biological Printing, by Material USD Million (2017-2022)
  • Table 131. Mexico 3D Biological Printing, by Component USD Million (2017-2022)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. 3D Biological Printing: by Application(USD Million)
  • Table 143. 3D Biological Printing Medical [Tissue and Organ Generation, Medical Pills, Prosthetic and Implants , by Region USD Million (2023-2028)
  • Table 144. 3D Biological Printing Dental] , by Region USD Million (2023-2028)
  • Table 145. 3D Biological Printing Biosensors , by Region USD Million (2023-2028)
  • Table 146. 3D Biological Printing Consumer/Personal Product Testing , by Region USD Million (2023-2028)
  • Table 147. 3D Biological Printing Bioinks , by Region USD Million (2023-2028)
  • Table 148. 3D Biological Printing Food and Animal Product , by Region USD Million (2023-2028)
  • Table 149. 3D Biological Printing: by Technology(USD Million)
  • Table 150. 3D Biological Printing Magnetic Levitation , by Region USD Million (2023-2028)
  • Table 151. 3D Biological Printing Inkjet-based , by Region USD Million (2023-2028)
  • Table 152. 3D Biological Printing Syringe-based , by Region USD Million (2023-2028)
  • Table 153. 3D Biological Printing Laser-based , by Region USD Million (2023-2028)
  • Table 154. 3D Biological Printing Others , by Region USD Million (2023-2028)
  • Table 155. 3D Biological Printing: by Material(USD Million)
  • Table 156. 3D Biological Printing Cells , by Region USD Million (2023-2028)
  • Table 157. 3D Biological Printing Hydrogels , by Region USD Million (2023-2028)
  • Table 158. 3D Biological Printing Extracellular Matrices , by Region USD Million (2023-2028)
  • Table 159. 3D Biological Printing Biomaterials , by Region USD Million (2023-2028)
  • Table 160. 3D Biological Printing: by Component(USD Million)
  • Table 161. 3D Biological Printing 3D Bioprinters , by Region USD Million (2023-2028)
  • Table 162. 3D Biological Printing Biomaterials , by Region USD Million (2023-2028)
  • Table 163. 3D Biological Printing Scaffolds , by Region USD Million (2023-2028)
  • Table 164. South America 3D Biological Printing, by Country USD Million (2023-2028)
  • Table 165. South America 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 166. South America 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 167. South America 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 168. South America 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 169. Brazil 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 170. Brazil 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 171. Brazil 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 172. Brazil 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 173. Argentina 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 174. Argentina 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 175. Argentina 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 176. Argentina 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 177. Rest of South America 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 178. Rest of South America 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 179. Rest of South America 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 180. Rest of South America 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 181. Asia Pacific 3D Biological Printing, by Country USD Million (2023-2028)
  • Table 182. Asia Pacific 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 183. Asia Pacific 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 184. Asia Pacific 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 185. Asia Pacific 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 186. China 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 187. China 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 188. China 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 189. China 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 190. Japan 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 191. Japan 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 192. Japan 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 193. Japan 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 194. India 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 195. India 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 196. India 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 197. India 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 198. South Korea 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 199. South Korea 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 200. South Korea 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 201. South Korea 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 202. Taiwan 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 203. Taiwan 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 204. Taiwan 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 205. Taiwan 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 206. Australia 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 207. Australia 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 208. Australia 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 209. Australia 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 210. Rest of Asia-Pacific 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 211. Rest of Asia-Pacific 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 212. Rest of Asia-Pacific 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 213. Rest of Asia-Pacific 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 214. Europe 3D Biological Printing, by Country USD Million (2023-2028)
  • Table 215. Europe 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 216. Europe 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 217. Europe 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 218. Europe 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 219. Germany 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 220. Germany 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 221. Germany 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 222. Germany 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 223. France 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 224. France 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 225. France 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 226. France 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 227. Italy 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 228. Italy 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 229. Italy 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 230. Italy 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 231. United Kingdom 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 232. United Kingdom 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 233. United Kingdom 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 234. United Kingdom 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 235. Netherlands 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 236. Netherlands 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 237. Netherlands 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 238. Netherlands 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 239. Rest of Europe 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 240. Rest of Europe 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 241. Rest of Europe 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 242. Rest of Europe 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 243. MEA 3D Biological Printing, by Country USD Million (2023-2028)
  • Table 244. MEA 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 245. MEA 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 246. MEA 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 247. MEA 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 248. Middle East 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 249. Middle East 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 250. Middle East 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 251. Middle East 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 252. Africa 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 253. Africa 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 254. Africa 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 255. Africa 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 256. North America 3D Biological Printing, by Country USD Million (2023-2028)
  • Table 257. North America 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 258. North America 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 259. North America 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 260. North America 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 261. United States 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 262. United States 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 263. United States 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 264. United States 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 265. Canada 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 266. Canada 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 267. Canada 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 268. Canada 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 269. Mexico 3D Biological Printing, by Application USD Million (2023-2028)
  • Table 270. Mexico 3D Biological Printing, by Technology USD Million (2023-2028)
  • Table 271. Mexico 3D Biological Printing, by Material USD Million (2023-2028)
  • Table 272. Mexico 3D Biological Printing, by Component USD Million (2023-2028)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global 3D Biological Printing: by Application USD Million (2017-2022)
  • Figure 5. Global 3D Biological Printing: by Technology USD Million (2017-2022)
  • Figure 6. Global 3D Biological Printing: by Material USD Million (2017-2022)
  • Figure 7. Global 3D Biological Printing: by Component USD Million (2017-2022)
  • Figure 8. South America 3D Biological Printing Share (%), by Country
  • Figure 9. Asia Pacific 3D Biological Printing Share (%), by Country
  • Figure 10. Europe 3D Biological Printing Share (%), by Country
  • Figure 11. MEA 3D Biological Printing Share (%), by Country
  • Figure 12. North America 3D Biological Printing Share (%), by Country
  • Figure 13. Global 3D Biological Printing share by Players 2022 (%)
  • Figure 14. Global 3D Biological Printing share by Players (Top 3) 2022(%)
  • Figure 15. Global 3D Biological Printing share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Organovo Holdings Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Organovo Holdings Inc. (United States) Revenue: by Geography 2022
  • Figure 19. EnvisionTEC (United States) Revenue, Net Income and Gross profit
  • Figure 20. EnvisionTEC (United States) Revenue: by Geography 2022
  • Figure 21. Nano3D Biosciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Nano3D Biosciences, Inc. (United States) Revenue: by Geography 2022
  • Figure 23. Cyfuse Biomedical K.K. (Japan) Revenue, Net Income and Gross profit
  • Figure 24. Cyfuse Biomedical K.K. (Japan) Revenue: by Geography 2022
  • Figure 25. BioBots (United States) Revenue, Net Income and Gross profit
  • Figure 26. BioBots (United States) Revenue: by Geography 2022
  • Figure 27. Aspect Biosystems Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Aspect Biosystems Ltd. (United States) Revenue: by Geography 2022
  • Figure 29. 3Dynamic Systems Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. 3Dynamic Systems Ltd (United Kingdom) Revenue: by Geography 2022
  • Figure 31. Stratavs (Israel) Revenue, Net Income and Gross profit
  • Figure 32. Stratavs (Israel) Revenue: by Geography 2022
  • Figure 33. Medpain (United States) Revenue, Net Income and Gross profit
  • Figure 34. Medpain (United States) Revenue: by Geography 2022
  • Figure 35. Formlabs (United States) Revenue, Net Income and Gross profit
  • Figure 36. Formlabs (United States) Revenue: by Geography 2022
  • Figure 37. Global 3D Biological Printing: by Application USD Million (2023-2028)
  • Figure 38. Global 3D Biological Printing: by Technology USD Million (2023-2028)
  • Figure 39. Global 3D Biological Printing: by Material USD Million (2023-2028)
  • Figure 40. Global 3D Biological Printing: by Component USD Million (2023-2028)
  • Figure 41. South America 3D Biological Printing Share (%), by Country
  • Figure 42. Asia Pacific 3D Biological Printing Share (%), by Country
  • Figure 43. Europe 3D Biological Printing Share (%), by Country
  • Figure 44. MEA 3D Biological Printing Share (%), by Country
  • Figure 45. North America 3D Biological Printing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Organovo Holdings Inc. (United States)
  • EnvisionTEC (United States)
  • Nano3D Biosciences, Inc. (United States)
  • Cyfuse Biomedical K.K. (Japan)
  • BioBots (United States)
  • Aspect Biosystems Ltd. (United States)
  • 3Dynamic Systems Ltd (United Kingdom)
  • Stratavs (Israel)
  • Medpain (United States)
  • Formlabs (United States)
Select User Access Type

Key Highlights of Report


Apr 2023 241 Pages 56 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global 3D Biological Printing Market Quantitative research analysis
Global 3D Biological Printing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Organovo Holdings Inc. (United States), EnvisionTEC (United States), Nano3D Biosciences, Inc. (United States), Cyfuse Biomedical K.K. (Japan), BioBots (United States), Aspect Biosystems Ltd. (United States), 3Dynamic Systems Ltd (United Kingdom), Stratavs (Israel), Medpain (United States) and Formlabs (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increase in Usage of 3d Printing in Cosmetic Surgeries " is seen as one of major influencing trends for 3D Biological Printing Market during projected period 2022-2028.
The 3D Biological Printing market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global 3D Biological Printing Market Report?

Have a Query? Click Here

Other Related Reports

Injectable Bone Substitute Comprehensive Study by Type (Natural Injectable Bone Substitute, Synthetic Injectable Bone Substitute), Application (Hospital, Clinic) Players and Region - Global Market Ou...
$ 3500
Digital Healthcare Comprehensive Study by Application (Patients, Healthcare Providers, Pharmaceutical Companies, Others), Services (Monitoring Services, Independent Aging Solutions, Diagnosis Service...
$ 3750
Cephalometric Radiograph Comprehensive Study by Type (Digital X-ray Systems, Analog X-ray Systems), Application (Diagnostic, Therapeutic, Cosmetic, Forensic), End-User (Dental Hospitals and Clinics, ...
$ 3450
4D Printing in Healthcare Comprehensive Study by Type (Fused Deposition Modelling (FDM), PolyJet, Stereolithography, Others), Application (Medical Models, Patient-Specific Implants, Surgical Guides),...
$ 3750
Infusion Pump Software Comprehensive Study by Type (Clinical Workflow, Dose-error reduction software (DERS), Infusion rate calculating software, Others), Application (Pediatrics and Neonatology, Anti...
$ 3650
Intraoral Imaging System Comprehensive Study by Type (2D Imaging system, 3D Imaging System), Application (Diagnostic Applications, Therapeutic Applications, Cosmetic Applications, Forensic Applicatio...
$ 3750